C4 Therapeutics (CCCC) Debt Ratio (2020 - 2023)

C4 Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.03 for Q2 2023.

• In Q2 2023, Debt Ratio rose 22.03% year-over-year to 0.03; the TTM figure through Jun 2023 stood at 0.03 (up 22.03% YoY), while the FY2022 annual figure was 0.03, up 25.42% from the prior year.
• Debt Ratio was 0.03 for Q2 2023 at C4 Therapeutics, roughly flat from 0.03 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.04 in Q3 2020 to a low of 0.02 in Q2 2021.
• Historically, Debt Ratio has averaged 0.03 across 4 years, with a median of 0.02 in 2020.
• The sharpest annual moves came in 2021 and 2023: Debt Ratio slumped 51.64% in 2021, then gained 29.73% in 2023.
• A 4-year view of Debt Ratio shows it stood at 0.03 in 2020, then retreated by 15.42% to 0.02 in 2021, then climbed by 25.42% to 0.03 in 2022, then rose by 3.41% to 0.03 in 2023.
• The last three Debt Ratio figures came in at 0.03 (Q2 2023), 0.03 (Q1 2023), and 0.03 (Q4 2022), per Business Quant data.